Study overturns basic tenet in leukemia biology
Scientists thought they understood the steps leading to acute myeloid leukemia. But one of the basic tenets in that understanding turns out to be unsound, according to researchers at the OHSU Knight...
A new prescription for cancer: Exercise
Updated guidance details how physical activity, tailored to the individual, can reduce side effects and improve quality of life. “Take it easy” and “don’t overexert yourself” were common...
Accelerating discovery collaboratively with patients as partners: Q&A with Shannon McWeeney
Shannon McWeeney, Ph.D., works at the intersection of computer science, biostatistics, genetics and medicine, finding ways to speed cancer research past the bottlenecks stalling progress. She’s...
Dive into the science of precision cancer medicine at Knight School
Targeted therapy drugs have transformed the outlook for people diagnosed with one form of blood cancer, chronic myeloid leukemia. A disease with a three- to five-year life expectancy became, for...
‘Bone in a dish’ opens new window on cancer initiation, metastasis, bone healing
Researchers in Oregon have engineered a material that replicates human bone tissue with an unprecedented level of precision, from its microscopic crystal structure to its biological activity. They...
Help researchers understand Oregon’s cancer needs
A new survey from the OHSU Knight Cancer Institute aims to help researchers understand the cancer-related needs of Oregonians and inform ways to address those needs across the state. Figure:...
Microsoft enlists cancer researchers in a new data sharing initiative
The Cascadia Data Discovery Initiative intends to make it easier for cancer researchers to work with each other's data and analytical tools. Microsoft, a technology giant now worth more than $1...
How a deadly leukemia develops resistance to one of the newest targeted therapies
OHSU Knight Cancer Institute scientists have identified key gene networks and signaling pathways that cancerous cells in acute myeloid leukemia use to resist treatment with the drug venetoclax, one...
Before the Senate, an Oregon cancer researcher defends international collaborations
“The United States represents only five percent of the world’s population and we draw the best minds from all of the world," said Joe Gray, Ph.D. "So, what we don’t want to do is diminish our...
Bringing together the leaders in cancer early detection
The Early Detection of Cancer Conference is part of a long-term commitment to invest in early detection, to understand the biology behind early stage cancers, find new detection and screening...